Bacteremic vs Nonbacteremic Shigella Infections in the United States Veterans Health Administration, 2000-2024.

IF 3.8 4区 医学 Q2 IMMUNOLOGY
Open Forum Infectious Diseases Pub Date : 2025-08-13 eCollection Date: 2025-09-01 DOI:10.1093/ofid/ofaf488
Gina Oda, Joyce Chung, Cynthia Lucero-Obusan, Mark Holodniy
{"title":"Bacteremic vs Nonbacteremic <i>Shigella</i> Infections in the United States Veterans Health Administration, 2000-2024.","authors":"Gina Oda, Joyce Chung, Cynthia Lucero-Obusan, Mark Holodniy","doi":"10.1093/ofid/ofaf488","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Risk factors for <i>Shigella</i> bacteremia are poorly understood. Growing trends in antimicrobial resistance may make treatment of <i>Shigella</i> bacteremia more difficult. We identified risk factors for <i>Shigella</i> bacteremia among <i>Shigella</i> cases who received care in the US Veterans Health Administration (VHA).</p><p><strong>Methods: </strong>We identified adults cared for in VHA with <i>Shigella</i> infection from 2000 to 2024. <i>Shigella</i> bacteremic versus nonbacteremic infections were compared based on patient demographics, comorbidities, outcomes, <i>Shigella</i> species, and antimicrobial resistance. We performed log-binomial regression analysis to estimate association of risk factors with <i>Shigella</i> bacteremia.</p><p><strong>Results: </strong>Of a total of 1962 <i>Shigella</i> infections in 1861 unique patients, 34 (1.7%) had confirmed bacteremia when blood cultures were checked. <i>Shigella</i> species among bacteremia cases included 13 (38.2%) <i>Shigella flexneri</i> and 14 (41.2%) <i>Shigella sonnei</i>, and 7 (2.6%) <i>Shigella</i> nonspeciated. A total of 1266/1962 (64.5%) isolates were tested for antimicrobial susceptibility. No <i>Shigella</i> bacteremia isolates were multidrug resistant; however, isolates from 3 nonbacteremic cases were. All with <i>Shigella</i> bacteremia were hospitalized and 1/34 (2.9%) died within 30 days of infection. Comparing characteristics of patients with <i>Shigella</i> bacteremic versus nonbacteremic infections and adjusting for potential confounders, age ≥65 years and HIV were independent risk factors for <i>Shigella</i> bacteremia (adjusted risk ratio [95% confidence interval] 2.90 [1.46-5.76] and 2.37 [1.11-5.06], respectively).</p><p><strong>Conclusions: </strong>Clinicians should be aware that patients who are elderly and/or have HIV are at higher risk for <i>Shigella</i> bacteremia and that these infections can be severe, requiring hospitalization. At this time, multidrug resistant <i>Shigella</i> strains have not been detected among bacteremic patients in VHA.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"12 9","pages":"ofaf488"},"PeriodicalIF":3.8000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418091/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ofid/ofaf488","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Risk factors for Shigella bacteremia are poorly understood. Growing trends in antimicrobial resistance may make treatment of Shigella bacteremia more difficult. We identified risk factors for Shigella bacteremia among Shigella cases who received care in the US Veterans Health Administration (VHA).

Methods: We identified adults cared for in VHA with Shigella infection from 2000 to 2024. Shigella bacteremic versus nonbacteremic infections were compared based on patient demographics, comorbidities, outcomes, Shigella species, and antimicrobial resistance. We performed log-binomial regression analysis to estimate association of risk factors with Shigella bacteremia.

Results: Of a total of 1962 Shigella infections in 1861 unique patients, 34 (1.7%) had confirmed bacteremia when blood cultures were checked. Shigella species among bacteremia cases included 13 (38.2%) Shigella flexneri and 14 (41.2%) Shigella sonnei, and 7 (2.6%) Shigella nonspeciated. A total of 1266/1962 (64.5%) isolates were tested for antimicrobial susceptibility. No Shigella bacteremia isolates were multidrug resistant; however, isolates from 3 nonbacteremic cases were. All with Shigella bacteremia were hospitalized and 1/34 (2.9%) died within 30 days of infection. Comparing characteristics of patients with Shigella bacteremic versus nonbacteremic infections and adjusting for potential confounders, age ≥65 years and HIV were independent risk factors for Shigella bacteremia (adjusted risk ratio [95% confidence interval] 2.90 [1.46-5.76] and 2.37 [1.11-5.06], respectively).

Conclusions: Clinicians should be aware that patients who are elderly and/or have HIV are at higher risk for Shigella bacteremia and that these infections can be severe, requiring hospitalization. At this time, multidrug resistant Shigella strains have not been detected among bacteremic patients in VHA.

2000-2024年美国退伍军人健康管理局细菌性与非细菌性志贺氏菌感染
背景:志贺氏菌血症的危险因素了解甚少。抗菌素耐药性的增长趋势可能使志贺氏菌血症的治疗更加困难。我们确定了在美国退伍军人健康管理局(VHA)接受治疗的志贺氏菌病例中志贺氏菌血症的危险因素。方法:选取2000年至2024年在VHA接受治疗的成人志贺氏菌感染患者。根据患者人口统计学、合并症、结局、志贺氏菌种类和抗菌素耐药性对志贺氏菌菌血症感染和非菌血症感染进行比较。我们采用对数二项回归分析来估计危险因素与志贺氏菌血症的关系。结果:1861例患者1962例志贺氏菌感染中,34例(1.7%)经血培养证实菌血症。其中,福氏志贺氏菌13种(38.2%),sonne志贺氏菌14种(41.2%),非种志贺氏菌7种(2.6%)。对1266/1962株(64.5%)进行了药敏试验。志贺氏菌血症分离株无多重耐药;3例非菌血症病例的分离株呈阳性。所有志贺氏菌血症患者均住院治疗,1/34(2.9%)患者在感染30天内死亡。比较志贺氏菌血症与非菌血症感染患者的特征并校正潜在混杂因素后,年龄≥65岁和HIV是志贺氏菌血症的独立危险因素(校正风险比[95%置信区间]分别为2.90[1.46-5.76]和2.37[1.11-5.06])。结论:临床医生应该意识到,老年人和/或艾滋病毒感染者发生志贺氏菌血症的风险更高,这些感染可能很严重,需要住院治疗。目前,在VHA的菌血症患者中尚未发现多重耐药志贺氏菌菌株。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Open Forum Infectious Diseases
Open Forum Infectious Diseases Medicine-Neurology (clinical)
CiteScore
6.70
自引率
4.80%
发文量
630
审稿时长
9 weeks
期刊介绍: Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信